 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Nutx releases breaking news on the inhabition of lung cancer and breast cancer. Watch this one run!! Nutraceutix acquires licensing rights to lung cancer inhibiting compound REDMOND, WASH. (June 18) BUSINESS WIRE -June 18, 1997--Nutraceutix, Inc. (OTC BB: NUTX) announced today that it had signed a definitive agreement with BioChemix, Inc. of Austin, Texas, for exclusive worldwide rights to market products containing the patented compound Calcium D-glucarate for the inhibition of lung cancer. Developed by researchers at various institutions including M.D. Anderson Cancer Center at the University of Texas, Calcium D-glucarate is a compound found naturally in certain fruits and vegetables. BioChemix is a technology transfer company whose principals are researchers at cancer research institutions. Terms of the licensing agreement were not disclosed. "We believe the availability of this compound will be especially attractive to the estimated 50 million former smokers who have already taken an important step to improve heir health, but it will also appeal to people who must live or work in smoky environments and to the 40 million people who still smoke," said William St. John, Nutraceutix president. "This unique formulation of Calcium D-glucarate contains natural chemicals and antioxidants that provide some degree of protection against the potential carcinogenic harm imposed by elements found in cigarettes and other tobacco products." St. John stressed that the only guarantee an individual has against developing a smoking-related cancer or other illness is to give up smoking. He pointed out, though, that while smoking cessation substantially and immediately reduces risks of heart and respiratory diseases, it can take decades for risk of lung cancer to return to normal levels. "Calcium D-glucarate provides an increased degree of protection during those years," he said. Nutraceutix intends to market this unique formulation of Calcium D-glucarate as a daily health supplement. A derivative of Calcium D-glucarate, glucaric acid, is found in low concentrations in the human body as a natural protective compound. The company also received first rights to the applications of the patent to breast cancer prevention. Nutraceutix researches, develops, manufactures and distributes health promoting natural compounds, food ingredients and animal health products. Founded in 1983, the company earlier this year increased its production capacity eight-fold to keep pace with its rapidly expanding sales. --30--KS/se* CONTACT: William St. John, 800/548-3222 OR Wiley Brooks or Susanne Rosenkranz, 800/775-5577 | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |